Jacob, S., Krentz, A. J., Deanfield, J., & Rydén, L. (2021). Evolution of Type 2 Diabetes Management from a Glucocentric Approach to Cardio-Renal Risk Reduction: The New Paradigm of Care. Drugs, 81(12), 1373. https://doi.org/10.1007/s40265-021-01554-6
Chicago Style (17th ed.) CitationJacob, Stephan, Andrew J. Krentz, John Deanfield, and Lars Rydén. "Evolution of Type 2 Diabetes Management from a Glucocentric Approach to Cardio-Renal Risk Reduction: The New Paradigm of Care." Drugs 81, no. 12 (2021): 1373. https://doi.org/10.1007/s40265-021-01554-6.
MLA (9th ed.) CitationJacob, Stephan, et al. "Evolution of Type 2 Diabetes Management from a Glucocentric Approach to Cardio-Renal Risk Reduction: The New Paradigm of Care." Drugs, vol. 81, no. 12, 2021, p. 1373, https://doi.org/10.1007/s40265-021-01554-6.